February 19, 2019
(Reuters) – Medical device maker Medtronic Plc on Tuesday reported a 2.4 percent rise in third-quarter revenue, driven by higher sales in surgical products unit and restorative therapies group.
Net income attributable to Medtronic was $1.27 billion, or 94 cents per share, in the quarter ended Jan. 25, compared with a loss of $1.39 billion, or $1.03 per share, a year earlier, when it recorded a tax-related charge.
Revenue rose to $7.55 billion from $7.37 billion a year earlier.
(Reporting by Manogna Maddipatla and Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur)